Today Johnson & Johnson settled five of its lawsuits claiming that its antipsychotic drug Risperdal caused boys to grow breast tissue. The hearing took place in Philadelphia, but the terms of the settlements were not disclosed.
The settlement of these cases comes on the heels of J&J’s efforts to keep former FDA chief David Kessler from taking the stand to testify about the drug company’s illegal promotion of the drug to children. Plaintiffs’ attorneys allege that J&J hid evidence that the drug caused hormonal changes that could trigger breast development in boys, and trained its pharmaceutical representatives to downplay this information in its doctors’ visits.
Despite denying this information and claiming that this breast development was a normal part of puberty, J&J settled these five bellwether cases.